{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Return to UT MD Anderson
The University of Texas MD Anderson Cancer Center
  • Sign In
  • Home
  • Live
  • On-Demand
  • RSS/Grand Rounds
  • Non-Accredited
  • About
  • Contact Us
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

UT MD Anderson workforce members:  Select " UT MD ANDERSON LOGIN" and enter your UT MD Anderson email address and password.

Guests (all other than UT MD Anderson workforce members): Select "GUEST LOGIN" and enter your email address and password.

UT MD ANDERSON LOGIN
GUEST LOGIN
Enter your email and password to login:

*
*
Login

New to CloudCME? Create an Account:

Create New Account
Back to Login Provider Forgot Your Password?

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Email is required Invalid: Enter valid email address
First Name is required
Last Name is required
Password is required


Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =
Confirm password

Passwords must match
Password must be between 8 and 16 characters and contain the following:
•at least 1 upper case character
•at least 1 lower case character
•at least 1 numerical character
•at least 1 special character

  • -- Select Degree --
  • AA
  • AAS
  • ADN
  • BA
  • BS
  • BSN
  • DDS
  • DMD
  • DMin
  • DNP
  • DO
  • DrPH
  • DVM
  • DVM,PhD
  • EdD
  • JD
  • MA
  • MBA
  • MBBS
  • MBBS,MD
  • MD
  • MD, MBA
  • MD, MPH
  • MD, PhD
  • MDiv
  • MEd
  • MHA
  • MPA
  • MPH
  • MS
  • MSN
  • MSW
  • None
  • Other
  • PharmD
  • PharmD, PhD
  • PhD
  • PsyD
Degree is required
Please enter your degree:
You must enter a degree

Profession is required




Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.

please enter a term to search
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

A Comprehensive Board Review in Hematology and Medical Oncology - 2026


LIVE
A Comprehensive Board Review in Hematology and Medical Oncology - 2026 Banner

  • Overview
  • Faculty
  • Brochure
  • Register
Add to Calendar A Comprehensive Board Review in Hematology and Medical Oncology - 2026 9/14/2026 8:00:00 AM 9/19/2026 5:30:00 PM America/Chicago For More Details: https://mdanderson.cloud-cme.com/HMOBR2026 Description: The course is a 6-day comprehensive review of current standards and practices in the management of patients with blood disorders and malignancy. The course is designed to enable the participant to effectively prepare for the American Board of Internal Medicine certification and recertification examinations in Hematology and Medical Oncology. Advances in clinical pharmacology, molecular genetics and risk assessment,... MD Anderson - Virtual false MM/DD/YYYY


Date & Location
Monday, September 14, 2026, 8:00 AM - Saturday, September 19, 2026, 5:30 PM, MD Anderson - Virtual

Target Audience
Specialties - Colon and Rectal Surgery, Gynecologic Oncology, Hematology, Medical Oncology, Neurological Surgery, Obstetrics and Gynecology, Thoracic Surgery, Urology
Professions - Nurse - APRN, Nurse - LVN, Nurse - RN, Pharmacist, Pharmacy Technician, Physician (MD or DO), Student or Trainee

Credits
AMA PRA Category 1 Credits™ (51.25 hours), ABIM MOC Part 2 (51.25 hours), Non-Physician Attendance (51.25 hours)

Overview
The course is a 6-day comprehensive review of current standards and practices in the management of patients with blood disorders and malignancy. The course is designed to enable the participant to effectively prepare for the American Board of Internal Medicine certification and recertification examinations in Hematology and Medical Oncology. Advances in clinical pharmacology, molecular genetics and risk assessment, and radiation oncology will be included.

Objectives
At the conclusion of this activity, learners will be able to:

  1. Apply knowledge gained to prepare for the hematology and medical oncology subspecialty and recertification examinations in hematology and medical oncology.
  2. Utilize current standards of care for patients with cancer, blood disorders and malignancies.
  3. Demonstrate proficiency of knowledge in hematology and medical oncology.
  4. Incorporate recent advances in management of hematologic and oncologic patients.

Registration

A Virtual Live Streaming Course

The Comprehensive Board Review in Hematology and Medical Oncology will be virtual. This program will be presented only as a live streaming course.

COMPREHENSIVE PROGRAM MATERIAL AVAILABLE FOR NON-ATTENDEES

CE Credits and MOC Points are awarded only by attending the virtual course. Credits and points can not be awarded by watching the on-demand videos after to course has adjourned.

For more information to purchase course material.


PLANNING COMMITTEE
MD Anderson Cancer Center
Sharon Giordano, MD, MPH, Co-Director
Tapan Kadia, MD, Co-Director
Shreyaskumar Patel, MD
Alessandra Ferrajoli, MD
Nishin Bhadka, MD
Felisha Estelle


Baylor College of Medicine
Martha Mims, MD, PhD, Co-Director

PRESENTATIONS
Course syllabus will not be printed. Presentations (slides) will be available online via the course platform and Canvas. The PowerPoint presentations will be posted online as PDFs prior to the conference. You will receive an invitation email with directives to log in Canvas.

  • The Full Conference and Oncology Session will begin at 7:30 a.m. (CDT) on Monday, September 14.  The Oncology Session will adjourn at 12:00 p.m. on Friday, September 18.  The Full Conference will adjourn at 5:00 p.m. on Saturday, September 19.

  • The Hematology Session will begin at 7:30 a.m. (CDT) on Thursday, September 17 and adjourn at 5:00 p.m. on Saturday, September 19.

Advanced registration is encouraged.  Please see the registration fees below.

*NOTE: The conference registration fee includes the tuition, access to course virtual platform with PDFs of the slides and Canvas - online web-based system with recorded videos.

The early bird registration deadline is Monday, August 24, 2026.

Telephone registrations are not accepted.

We accept the following forms of payment:

  • Credit Cards (MasterCard, VISA, and American Express)

  • Check (payable through U.S. banks only)

  • Mail to: Continuing Professional Education – Unit 1781, The University of Texas MD Anderson Cancer Center, P.O. Box 301407, Houston, TX 77230-1407

Make check payable to:  The University of Texas MD Anderson Cancer Center

When registering online a receipt (confirmation letter) will be automatically emailed to the e-mail address you list on the registration form.

CONFERENCE REGISTRATION FEES

Before
July 21, 2026

Before
August 24, 2026

After
August 24, 2026

Full Conference - Physician/Scientist/Pharmacist (MD, DO, PhD, PharmD)

$1,200

$1,300

$1,400

Full Conference - Resident/Fellow/UT MD Anderson Associate*

$800

$900

$1,000

Full Conference - Physician Assistant/Nurse/Advanced Nurse Practitioner*

$450

$450

$450

Full Conference - UT MD Anderson/Baylor Faculty/Staff

$500

$500

$500

Full Conference - UT MD Anderson/Baylor Clinical Fellow*

Exempt

Exempt

Exempt

Oncology Session - 4.5 days (Monday - Friday Noon) - Physician/Scientist/Pharmacist (MD, DO, PhD, PharmD)

$650

$700

$750

Oncology Session - 4.5 days (Monday - Friday Noon) - Resident/Fellow/UT MD Anderson Associate*

$450

$500

$550

Hematology Session - 3 days (Thursday - Saturday) - Physician/Scientist/Pharmacist (MD, DO, PhD, PharmD)

$550

$600

$650

Hematology Session - 3 days (Thursday - Saturday) - Resident/Fellow/UT MD Anderson Associate*

$350

$400

$450

* A letter of introduction from the program director or chairperson with registration form is required to claim this reduced fee.

REFUND/CANCELLATION POLICY
The registration fee, minus a $50 administrative handling fee, is refundable if a written request is received on or before Monday, August 24, 2026.  No refunds will be granted after that date.  The request for a registration refund must include the tax identification number of the company or institution if registration was paid by a company or institution check.  For additional information, contact Continuing Professional Education at 713-792-2223 or toll free at 866-849-5866.

Continuing Professional Education reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary.  Each registrant will be notified by mail, e-mail, or at the phone or fax numbers given on the registration form.

In case of activity cancellation, the liability of Continuing Professional Education is limited to the registration fee.  Continuing Professional Education will refund the full registration fee.

Continuing Professional Education reserves the right to limit the number of participants in a program and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available. 

Please let us know what specific topics, issues, or questions you wish to see addressed or emphasized in this activity by emailing Continuing Professional Education at [email protected]. All responses will be forwarded to the Program Directors for consideration.

EVALUATION
An online course evaluation tool will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status. Participants will also have the opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics.

SPECIAL ASSISTANCE
Contact Felisha Estelle in Continuing Professional Education at 713-745-0083 or 1-866-531-MOBR (6627) if you have any ADA accommodation needs.





Accreditation

In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Designation
The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 51.25 AMA PRA Category 1 CreditsTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 Maintenance of Certification

American Board of Internal Medicine (ABIM)
Successful completion of this CE activity, which includes participation in the evaluation component, enables the participant to earn up to 51.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CE credits claimed for the activity. It is the CE activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. 

In order to receive MOC points, you must pass the post-test with a score of 70% or higher.

Participant completion data will be shared with and transmitted to the ACCME on the participant’s behalf. 


Additional Information

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

 


You are not logged in.

Please click the button below to login or create a new account before continuing.

Login or Create Account

The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.

Mitigation of Relevant Financial Relationships

The University of Texas MD Anderson Cancer Center adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Member Information
Role in activity
Nature of Relationship(s) / Name of Ineligible Company(s)
Sharon H. Giordano, MD, FASCO
Professor
The University of Texas MD Anderson Cancer Center
Activity Co-Director, Content Reviewer, Faculty
Nothing to disclose
Tapan M. Kadia, MD
Professor
The University of Texas MD Anderson Cancer Center
Activity Co-Director, Faculty
Grant or research support-Bristol-Myers Squibb Company|Honoraria-DAVA Oncology|Speakers Bureau-CURE|Honoraria-DrenBio|Grant or research support-Dren Bio|Grant or research support-Celgene Corporation (Relationship has ended)|Grant or research support-BMS|Honoraria-Biologix (Relationship has ended)|Grant or research support-Janssen Biotech, Inc. (Relationship has ended)|Grant or research support-Incyte Corporation|Grant or research support-Astex|Grant or research support-Abcuro|Grant or research support-Pfizer Inc.|Honoraria-Hikma Pharmaceuticals|Consulting Fee-Genzyme Corporation (Relationship has ended)|Grant or research support-Glycomimetics|Consulting Fee-Sellas|Grant or research support-Sellas|Grant or research support-AbbVie Inc.|Grant or research support-Amgen Inc. (Relationship has ended)|Grant or research support-Genentech, Inc.|Grant or research support-Ascentage|Grant or research support-Cellenkos (Relationship has ended)|Grant or research support-AstraZeneca US (Relationship has ended)|Grant or research support-Astellas Scientific and Medical Affairs, Inc. (Relationship has ended)|Paid consultant-AbbVie Inc.|Paid consultant-Genentech, Inc.|Grant or research support-Genfleet|Grant or research support-Sellas, Inc|Grant or research support-Delta Fly Pharma (Relationship has ended)|Grant or research support-Jazz Pharmaceuticals|Paid consultant-Jazz Pharmaceuticals|Paid consultant-Novartis Pharmaceuticals Corporation|Paid consultant-Daiichi Sankyo, Inc.|Paid consultant-Agios Pharmaceuticals Inc.|Consulting Fee-PinotBio (Relationship has ended)|Consulting Fee-Sanofi US (Relationship has ended)|Paid consultant-Pfizer Inc.|Grant or research support-Regeneron Pharmaceuticals, Inc.|Consulting Fee-Servier Pharmaceuticals|Consulting Fee-Syndax|Consulting Fee-Kura
Martha Mims, MD, PhD
Professor and Section Chief, Hematology/Oncology
Baylor College of Medicine
Activity Co-Director, Faculty
Stocks or stock options, excluding diversified mutual funds-Amgen Inc.|Stocks or stock options, excluding diversified mutual funds-Biogen Inc.|Grant or research support-Janssen Biotech, Inc. (Relationship has ended)|Grant or research support-Celgene Corporation (Relationship has ended)|Grant or research support-Incyte Corporation (Relationship has ended)|Grant or research support-inovio
Teresa Moon, MD
MD Anderson Cancer Center
CE Reviewer
Nothing to disclose
Felisha Estelle, BBA
CE Activity Planner
The University of Texas MD Anderson Cancer Center
CPE Planner
Nothing to disclose
Rodabe N. Amaria, MD
Associate Professor, Melanoma Medical Oncology
The University of Texas MD Anderson Cancer Center
Faculty
Grant or research support-Novartis Pharmaceuticals Corporation (Relationship has ended)|Grant or research support-KSQ|Grant or research support-Erasca|Grant or research support-Erasca|Consulting Fee-Obsidian |Grant or research support-Merck Sharp & Dohme Corp. (any division) (Relationship has ended)|Grant or research support-Bristol-Myers Squibb Company (Relationship has ended)|Grant or research support-Regeneron Pharmaceuticals, Inc.|Grant or research support-Iovance (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Novartis Pharmaceuticals Corporation (Relationship has ended)|Grant or research support-Obsidian|Grant or research support-OnKure|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Bristol-Myers Squibb Company (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-TIL Working Group|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Nektar (Relationship has ended)
Kenneth Bauer, MD, Physician
Professor
Beth Israel Deaconess Medical Center
Faculty
Consulting Fee-Sanofi US (Relationship has ended)
Alexandre Bazinet, MD
Assistant Professor
MD Anderson Cancer Center
Faculty
Nothing to disclose
Nancy Berliner, MD
Chief, Division of Hematology
Brigham and Women's Hospital
Faculty
Advisor-Sobi|Advisor-Electra
Abenaa M. Brewster, MD
Professor
The University of Texas MD Anderson Cancer Center
Faculty
Nothing to disclose
Bradley Carthon, MD, PhD, MD, PhD
Associate Professor
Emory Healthcare
Faculty
Carla Casulo, MD
University of Rochester
Faculty
Honoraria- Mashup Media (Relationship has ended)|Consulting Fee- Mashup Media (Relationship has ended)|Consulting Fee-Bristol-Myers Squibb Company|Honoraria-Bristol-Myers Squibb Company|Consulting Fee-AbbVie Inc.|Honoraria-AbbVie Inc.|Consulting Fee-Genentech, Inc.|Honoraria-Genentech, Inc.|Grant or research support-Genmab|Grant or research support-Gilead Sciences, Inc.|Grant or research support-Genentech, Inc.|Membership on Advisory Committees or Review Panels, Board Membership, etc.-FL Cures Foundation (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-American Society of Hematology|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Lymphoma Research Foundation|Honoraria-Genmab|Consulting Fee-Genmab
Mariana C. Chavez MacGregor, MD, Profesor
Professor
The University of Texas MD Anderson Cancer Center
Faculty
Jorge Cortes, MD
O'Neal Cancer Center at the University of Alabama at Birmingham
Faculty
Consulting Fee-Novartis Pharmaceuticals Corporation|Consulting Fee-Ascentage|Consulting Fee-Xspray|Consulting Fee-Azurity|Consulting Fee-Johnson & Johnson (any division)|Consulting Fee
Courtney D. DiNardo, MD
Associate Professor
The University of Texas MD Anderson Cancer Center
Faculty
Honoraria-AbbVie Inc.|Honoraria-Syndax|Honoraria-Kura|Honoraria-Rigel|Honoraria-Daiichi Sankyo, Inc.|Honoraria-Genentech, Inc.|Honoraria-Astellas Scientific and Medical Affairs, Inc. (Relationship has ended)|Honoraria-Bristol-Myers Squibb Company|Honoraria-GlaxoSmithKline|Honoraria-Novartis Pharmaceuticals Corporation (Relationship has ended)|Honoraria-Servier Pharmaceuticals|Honoraria-Immunogen (Relationship has ended)|Advisor-Ellipses
Ravin J. Garg, MD
Medical Doctor
Maryland Oncology Hematology/US Oncology and Assistant Professor of Oncology/Johns Hopkins Hospital
Faculty
Nothing to disclose
Carl M. Gay, MD
The University of Texas MD Anderson Cancer Center
Faculty
Advisor-Pharmacosmos (Relationship has ended)|Advisor-Boehringer Ingelheim|Advisor-Amgen Inc. (Relationship has ended)|Advisor-BeOne (Relationship has ended)|Advisor-AstraZeneca US (Relationship has ended)|Advisor-Jazz Pharmaceuticals|Grant or research support-AstraZeneca US|Grant or research support-BioNTech|Grant or research support-IDEAYA|Speakers Bureau-AstraZeneca US (Relationship has ended)|Advisor-Daiichi Sankyo, Inc. (Relationship has ended)|Speakers Bureau-Dava Oncology (Relationship has ended)
Timothy D. Gilligan, MD, FASCO, FACH
Associate Professor & Vice-Chair for Education
Cleveland Clinic Taussig Cancer Institute
Faculty
Nothing to disclose
Betty Hamilton, MD
Cleveland Clinic
Faculty
Membership on Advisory Committees or Review Panels, Board Membership, etc.-Incyte Corporation|Grant or research support-Angiocrine|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Sanofi US|Membership on Advisory Committees or Review Panels, Board Membership, etc.-CSL Behring|Consulting Fee-T-Scan
Nasser H. Hanna, MD
Professor of Medicine
Indiana University
Faculty
Grant or research support-Merck Research Laboratories and the Office of the Chief Medical Officer Grants|Grant or research support-Genentech, Inc.
Yvonne J. Heung, MD
Associate Professor
MD Anderson Cancer Center
Faculty
Nothing to disclose
Emily Hinchcliff, MD
Assistant Professor
Northwestern Medicine
Faculty
Speakers Bureau-AbbVie Inc.|Consulting Fee-Merck Research Laboratories and the Office of the Chief Medical Officer Grants
Mimi I. Hu, MD
Professor
The University of Texas MD Anderson Cancer Center
Faculty
Grant or research support-Lilly USA, LLC|Speakers Bureau-Eli Lilly & Co (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Lilly USA, LLC
Claudine Isaacs, MD, FRCPC
Professor
Georgetown
Faculty
Consulting Fee-Genentech, Inc.|Consulting Fee-AstraZeneca US|Consulting Fee-Novartis Pharmaceuticals Corporation|Consulting Fee-PUMA|Consulting Fee-Pfizer Inc.|Consulting Fee-ION Solutions (Relationship has ended)|Consulting Fee-Gilead Sciences, Inc.|Consulting Fee-Merck Sharp & Dohme Corp. (any division)|Honoraria-Medscape|Honoraria-MJH Holdings|Royalties or Patent Beneficiary-Wolters Kluwer|Royalties or Patent Beneficiary-McGraw Hill|Consulting Fee-Artera|Consulting Fee-Ataraxis|Consulting Fee-Arvinas|Consulting Fee-Boehringer Ingelheim|Grant or research support-QuatumLeap|Other: Editor in Chief-Springer Nature
Inimfon Jackson, MD
MD Anderson Cancer Center
Faculty
Nothing to disclose
Eric Jonasch, MD
Professor
The University of Texas MD Anderson Cancer Center
Faculty
Consulting Fee-Aveo|Grant or research support-Bristol-Myers Squibb Company|Consulting Fee-Bristol-Myers Squibb Company|Grant or research support-ProFoundBio|Grant or research support-AbbVie Inc.|Grant or research support-Telix|Grant or research support-Aveo|Grant or research support-Corvus|Consulting Fee-Eisai, Inc.|Honoraria-Exelixis|Honoraria-Ipsen US|Honoraria-Merck Research Laboratories and the Office of the Chief Medical Officer Grants|Grant or research support-Merck Research Laboratories and the Office of the Chief Medical Officer Grants|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Novartis Pharmaceuticals Corporation|Honoraria-Nikang|Grant or research support-Nikang|Honoraria-Takeda (Relationship has ended)|Honoraria-DAVA
Hagop M. Kantarjian, MD
Chair, Leukemia
The University of Texas MD Anderson Cancer Center
Faculty
Grant or research support-AbbVie Inc.|Grant or research support-Amgen Inc.|Grant or research support-Pfizer Inc.|Grant or research support-Takeda|Consulting Fee-AbbVie Inc.|Consulting Fee-Amgen Inc.|Consulting Fee-Bristol-Myers Squibb Company|Consulting Fee-Pfizer Inc.|Consulting Fee-Takeda
Scott Kopetz, MD
Professor, GI Medical Oncology
The University of Texas MD Anderson Cancer Center
Faculty
Stocks or stock options, excluding diversified mutual funds-Lutris Pharmaceuticals (Relationship has ended)|Advisor-Lutris Pharmaceuticals (Relationship has ended)|Consulting Fee-Genentech, Inc.|Grant or research support-EMD Serono Inc.|Consulting Fee-Merck Research Laboratories and the Office of the Chief Medical Officer Grants|Grant or research support-Novartis Pharmaceuticals Corporation (Relationship has ended)|Grant or research support-Lilly USA, LLC|Consulting Fee-Boehringer Ingelheim|Grant or research support-Boehringer Ingelheim|Consulting Fee-Bayer HealthCare Pharmaceuticals, Inc.|Grant or research support-Daiichi Sankyo, Inc.|Consulting Fee-Pfizer Inc.|Grant or research support-Jazz Pharmaceuticals|Consulting Fee-Mirati Therapeutics|Consulting Fee-Flame Biosciences|Consulting Fee-Carina Biotechnology|Grant or research support-Sanofi US (Relationship has ended)|Grant or research support-Guardant Health|Grant or research support-Genentech, Inc.|Grant or research support-MedImmune (Relationship has ended)|Grant or research support-Amgen Inc.|Consulting Fee-Frontier Medicines|Consulting Fee-Replimune|Consulting Fee-Bristol-Myers Squibb-Medarex|Consulting Fee-Amgen|Consulting Fee-Tempus|Consulting Fee-Harbinger Oncology|Consulting Fee-Zentalis|Consulting Fee-AVEO|Consulting Fee-Tachyon Therapeutics|Consulting Fee-Agenus|Consulting Fee-Revolution Medicines|Consulting Fee-Kestrel Therapeutics|Consulting Fee-Roche|Grant or research support-BridgeBio|Grant or research support-Cardiff|Grant or research support-Zentalis|Grant or research support-Mirati (Relationship has ended)|Consulting Fee-Arcus Biosciences|Consulting Fee-AstraZeneca Pharmaceutical|Consulting Fee-BeiGene|Consulting Fee-Clasp Therapeutics|Consulting Fee-Cytovation|Consulting Fee-Dewpoint Therapeutics|Consulting Fee-Marengo Therapeutics|Consulting Fee- SageMedic|Consulting Fee-Servier|Consulting Fee-Sibylla|Consulting Fee-T-Cypher Bio|Consulting Fee-XAIRA|Consulting Fee-AmMax Bio|Consulting Fee-Ikena|Grant or research support-Pfizer Inc.|Grant or research support-BioMed Valley|Consulting Fee-Arvinas|Consulting Fee-AVEO|Consulting Fee-DeBiopharm|Consulting Fee-Gilead|Consulting Fee- Janssen|Consulting Fee-Kivu|Consulting Fee- Larkspur|Consulting Fee-Menarini Ricerche|Consulting Fee-Pierre Fabre|Consulting Fee-Sanofi|Consulting Fee-Verastem|Grant or research support-Frontier Medicines, |Grant or research support-Johnson & Johnson
Alfred Lee, MD, PhD
Yale School of Medicine
Faculty
Mark Lewis, MD
Intermountain Healthcare
Faculty
Jennifer K. Litton, MD
Professor
The University of Texas MD Anderson Cancer Center
Faculty
Nothing to disclose
Alice Ma, MD
Professor of Medicine
University of North Carolina
Faculty
Consulting Fee-Pfizer Inc. (Relationship has ended)
Claire Mach, PharmD
Clinical Pharmacy Specialist
Harris Health System
Faculty
L. Jeffrey Medeiros, MD
Chair - Hematopathology Adm
The University of Texas MD Anderson Cancer Center
Faculty
Nothing to disclose
Stephan Moll, MD
UNC Chapel Hill
Faculty
Nothing to disclose
Alison Moskowitz, MD
Memorial Sloan Kettering Cancer Center
Faculty
Other: speaking-Takeda Pharmaceuticals (Relationship has ended)|Advisor-Pfizer Inc.|Grant or research support-Pfizer Inc.|Grant or research support-Incyte Corporation|Grant or research support-Merck Sharp & Dohme Corp. (any division)|Honoraria-Merck Sharp & Dohme Corp. (any division) (Relationship has ended)|Grant or research support-Bristol-Myers Squibb Company|Grant or research support-Secura-Bio
Kerry O'Brien, MD
Medical Director Blood Bank
Beth Israel Deaconess Medical Center
Faculty
Nothing to disclose
Susan O'Brien, MD
Professor of Medicine
University of California Irvine
Faculty
Consulting Fee-AbbVie Inc.|Consulting Fee-Regeneron Pharmaceuticals, Inc. (Relationship has ended)|Consulting Fee-Pharmacyclics LLC|Consulting Fee-Johnson & Johnson (any division)|Consulting Fee-Janssen Biotech, Inc.|Consulting Fee-GlaxoSmithKline (Relationship has ended)|Consulting Fee-Genentech, Inc.|Consulting Fee-Bristol-Myers Squibb Company|Consulting Fee-AstraZeneca US|Grant or research support-Caribou|Consulting Fee-Autolus
Timothy Olson, MD, PhD
Medical Director, Blood and Marrow Transplant Program
Children's Hospital of Philadelphia
Faculty
Membership on Advisory Committees or Review Panels, Board Membership, etc.-Genetix|Consulting Fee-Vertex|Honoraria-Alexion (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Medexus|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Elixergin Therapeutics (Relationship has ended)
Antonio Omuro, MD
Stanford University
Faculty
Jacquelyn Powers, MD
Associate Professor
Baylor College of Medicine
Faculty
Nothing to disclose
S. Vincent Rajkumar, MD
Professor of Medicine
Mayo Clinic
Faculty
Nothing to disclose
Raajit Rampal, MD, PhD
Associate Member
MSKCC
Faculty
A. Koneti Rao, MD
Lewis Katz School of Medicine
Faculty
Nothing to disclose
Jose A. Rauh-Hain, MD
Assistant Professor
The University of Texas MD Anderson Cancer Center
Faculty
Honoraria-Merck Sharp & Dohme Corp. (any division) (Relationship has ended)
Caitlin R Rausch, PharmD, BCOP
Clinical Pharmacy Specialist
MD Anderson Cancer Center
Faculty
Advisor-Johnson & Johnson (any division) (Relationship has ended)
Bethany T Samuelson Bannow, MD, MCR
Associate Professor
Cleveland Clinic
Faculty
Samuel A. Shelburne III, MD
Professor
The University of Texas MD Anderson Cancer Center
Faculty
Nothing to disclose
Gerald A Soff, MD
Chief, Classical Hematology Service
University of Miami Health System/Sylvester Comprehensive Cancer Center
Faculty
Paolo Strati, MD
Associate Professor
MD Anderson Cancer Center
Faculty
Consulting Fee-Genentech, Inc.|Advisor-Incyte (Relationship has ended)|Advisor-Sobi (Relationship has ended)|Advisor-ADC Therapeutics (Relationship has ended)|Grant or research support-ADC Therapeutics|Advisor-Kite-Gilead (Relationship has ended)|Grant or research support-Gilead Sciences, Inc.|Advisor-AstraZeneca US (Relationship has ended)|Grant or research support-AstraZeneca US|Grant or research support-ALX Oncology|Advisor-AbbVie Inc.|Advisor-Genmab|Advisor-Ipsen US|Advisor-Novartis Pharmaceuticals Corporation|Consulting Fee-Lilly USA, LLC|Consulting Fee-Merck Sharp & Dohme Corp. (any division)
Senthil Sukumar, MD
Baylor College of Medicine
Faculty
Kaiwen Wang, PharmD
MD Anderson Cancer Center
Faculty
Advisor-Pfizer Inc. (Relationship has ended)|Advisor-Janssen Biotech, Inc. (Relationship has ended)|Advisor-Bayer HealthCare Pharmaceuticals, Inc.
Jason R. Westin, MD
Dr
MDACC
Faculty
Grant or research support-AstraZeneca US|Grant or research support-Allogene|Paid consultant-Allogene|Paid consultant-AbbVie Inc.|Paid consultant-Nurix|Grant or research support-Nurix|Paid consultant-Pfizer Inc.|Grant or research support-Merck Sharp & Dohme Corp. (any division) (Relationship has ended)|Paid consultant-ADC Therapeutics|Paid consultant-Morphosys|Paid consultant-Novartis Pharmaceuticals Corporation|Paid consultant-Gilead Sciences, Inc.|Paid consultant-Genentech, Inc.|Grant or research support-Johnson & Johnson (any division)|Grant or research support-Gilead Sciences, Inc.|Grant or research support-Bristol-Myers Squibb Company|Grant or research support-Morphosys|Grant or research support-Genentech, Inc.
William N. William Jr., MD
Medical Oncologist
Hospital BP
Brazil
Faculty
Consulting Fee-AstraZeneca US|Consulting Fee-Amgen Inc.|Consulting Fee-Bayer HealthCare Pharmaceuticals, Inc.|Consulting Fee-Boehringer Ingelheim|Consulting Fee-Bristol-Myers Squibb Company|Consulting Fee-Janssen Biotech, Inc.|Consulting Fee-Lilly USA, LLC|Consulting Fee-Merck Sharp & Dohme Corp. (any division)|Consulting Fee-Novartis Pharmaceuticals Corporation|Consulting Fee-Pfizer Inc.|Consulting Fee-Sanofi Genzyme|Consulting Fee-Genentech, Inc.
Robert A. Wolff, MD
Professor, GI Medical Oncology
The University of Texas MD Anderson Cancer Center
Faculty
Nothing to disclose
Harry H. Yoon, MD
Associate Professor
Mayo Clinic
Faculty
Membership on Advisory Committees or Review Panels, Board Membership, etc.-Daiichi Sankyo, Inc.|Membership on Advisory Committees or Review Panels, Board Membership, etc.-LSK Biopharma|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Jazz Pharmaceuticals|Other: Educator/Trainer of external academic speakers-Jazz Pharmaceuticals|Grant or research support-BeOne|Grant or research support-Amgen Inc.|Grant or research support-Macrogenics|Grant or research support-Merck Sharp & Dohme Corp. (any division)|Advisor-BeOne|Advisor-Macrogenics|Advisor-Merck Sharp & Dohme Corp. (any division)|Advisor-Amgen Inc.
Shreyaskumar Patel, MD
Professor - Sarcoma Medical Oncology
The University of Texas MD Anderson Cancer Center
Faculty, Planning Committee Member
Consulting Fee-Daiichi Sankyo, Inc.|Consulting Fee-Deciphera|Consulting Fee-Kura Oncology|Consulting Fee-Parabilis
Nishin Bhadkamkar, MD
Associate Professor
The University of Texas MD Anderson Cancer Center
Planning Committee Member
Nothing to disclose
Alessandra Ferrajoli, MD
Professor of Medicine
The University of Texas MD Anderson Cancer Center
Planning Committee Member
Membership on Advisory Committees or Review Panels, Board Membership, etc.-AbbVie Inc. (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Genentech, Inc. (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-AstraZeneca US (Relationship has ended)

The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd.
Houston, TX 77030
 Privacy policies   

©2026 The University of Texas MD Anderson Cancer Center
Contact Us: [email protected]

See us on Facebook See us on Twitter See us on Linked In See us on Instagram